Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-23
2011-08-23
Hui, San-Ming (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S360000, C514S383000, C544S236000, C548S262400
Reexamination Certificate
active
08003649
ABSTRACT:
The invention concerns bicyclic compounds of Formula Iwherein the integers X1, X2, X3, Ring A, R4, R5and m are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of androgen-receptor associated conditions.
REFERENCES:
patent: 2006039325 (2006-04-01), None
patent: 2008109104 (2008-09-01), None
RN 334500-45-7 Registry file of chemical abstract services entered STN on May 3, 2001.
RN 927049-23-8 Registry file of chemical abstract services entered STN on Mar. 18, 2007.
RN 930466-59-4 Registry file of chemical abstract services entered STN on Apr. 17, 2007.
RN 930503-83-6 Registry file of chemical abstract services entered STN on Apr. 17, 2007.
RN 931060-90-1 Registry file of chemical abstract services entered STN on Apr. 19, 2007.
Bioorg. Med. Chem. Lett. 2007; vol. 17; Issue 16, pp. 4579-4583.
Sep. 23, 2008 Novelty Search Results.
Vasaitis et. al. Androgen receptor inactivation contributes to antitumor efficacy of 17 -hydroxylase/17,20-lyase inhibitor 3 -hydroxy-17-(1H-benzimidazole-1-yl)androsta-5, 16-diene in prostate cancer; Molecular Cancer Therapeutics 2008;7(8). Aug. 2008; pp. 2348-2357.
Bradbury Robert Hugh
Hales Neil James
Rabow Alfred Arthur
Astrazeneca AB
Hui San-ming
Zarek Paul
LandOfFree
Bicyclic derivatives for use in the treatment of androgen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic derivatives for use in the treatment of androgen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic derivatives for use in the treatment of androgen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2622571